Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis

Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis

Abstract Backgrounds As previously reported, midazolam anesthesia exerts tumor-suppressing effects in non-small cell lung cancer (NSCLC), but the regulating effects of this drug on cisplatin-resistance in NSCLC have not been studied. Thus, we designed this study to investigate this issue and prelimi...

Full description

Bibliographic Details
Main Authors: Tingting Sun, Jing Chen, Xuechao Sun, Guonian Wang
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Cancer Cell International
Subjects:
Cisplatin-resistance
Midazolam
miR-194-5p
HOOK3
Non-small cell lung cancer
Online Access:https://doi.org/10.1186/s12935-021-02104-6

Internet

https://doi.org/10.1186/s12935-021-02104-6

Similar Items